TUB-010, a novel antibody drug conjugate with reduced nonspecific toxicity profile based on Tub-tag technology widens the therapeutic window of targeting CD30 by Gerlach, M, Schmitt, S, Cyprys, P, Kasper, M-A, Mai, I, Vermeer, MH, Horwitz, SM, Fingerle-Rowson, G, Vogl, A, Schumacher, D, Helma-Smets, J

Get full text